Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension

Table 2

Hemodynamic values at baseline and last follow-up.

OCT-LAR ()	Baseline	Last follow-up
WHVP (mmHg)	26.9 ± 2.3	22.6 ± 1.6	<0.05
FHVP (mmHg)	11.0 ± 1.1	9.8 ± 1.3	<0.05
HVPG (mmHg)	15.9 ± 2.4	12.8 ± 1.6	<0.05